● Single award · contract
Contract 75A50122C00076
A single federal award, with both ends of the trail linked.
$110.9M
total award value
2022
action date
104 mo
period
75A50122C00076
PIID
Description
This Cost-Plus-Fixed-Fee Contract with Mapp Biopharmaceutical, Inc. (Mapp or Contractor) Is for the Development of Mapp?s Therapeutic Intervention MBP091, as an Immunotherapy for the Treatment of Marburg Virus Infection.
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceCalifornia →
CategoryNAICS 541714PSC AN13
Competed?Not recorded✓ from source
Total (exact)$110,877,385
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.